Evidence map›Paper›PMID 34105091›Full record

ReviewCurrent HIV/AIDS reports2021

HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.

Ronnie M Gravett, Jeanne M Marrazzo

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ronnie M GravettDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, 1900 University Blvd, THT 215, Birmingham, AL, 35294, USA. rgravett@uabmc.edu.ORCID http://orcid.org/0000-0002-1614-758X
Jeanne M MarrazzoDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, 1900 University Blvd, THT 215, Birmingham, AL, 35294, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review highlights the intersection of the COVID-19, HIV, and STI pandemics and examines how harm reduction strategies can be applied broadly to controlling a pandemic. RECENT

findingsSince the onset of the COVID-19 pandemic, remarkable advances in the understanding of COVID-19 prevention, diagnosis, and treatment have been made at a much faster pace than prior pandemics, yet much more still remains to be discovered. Many of the strategies to control the COVID-19 pandemic mirror those employed to stem the HIV pandemic. Harm reduction principles used in the HIV pandemic can be applied to reduce the morbidity and mortality of the COVID-19 pandemic through effective prevention, detection, and treatment strategies.

Indexed as

Harm ReductionSARS-CoV-2ChemopreventionCOVID-19HIV InfectionsHumansSexually Transmitted DiseasesVaccinationCOVID-19Harm reductionHIVSARS-CoV-2Sexually transmitted infections

Identifiers

PMID34105091
PMCPMC8186366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.